buff.ly
Phase 2b JASMINE trial of nipocalimab demonstrates positive results for treatment of systemic lupus erythematosus
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug therapy, nipocalimab, met its primary endpoint and multiple key secondary…